Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Quadrivalent Influenza Split Virion Vaccine
CTR20180918Phase 3Completed
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent influenza split virion vaccine in influenza, sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started May 2019; status: completed.
02
Drugs
quadrivalent influenza split virion vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20180918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180918.